5th Annual MarketsandMarkets

Infectious Disease and Molecular Diagnostics Conference

21st – 22nd March 2024

London, UK

Implementing advanced technologies in the world of diagnostics.

The healthcare sector is undergoing significant transformations, largely due to advancements in technology, and the Diagnostics field has emerged as a pivotal catalyst in this evolution. Given its crucial role in treatment decisions, diagnostics must strive for speed, precision, and accuracy.

We are pleased to announce the 5th Annual Infectious Disease Diagnostics and Molecular Diagnostics Conference, organized by MarketsandMarkets. This esteemed event is scheduled to take place on the 21st and 22nd of March 2024 in London. The conference has been handcrafted to showcase the latest insights in diagnostics, explore emerging technologies and their applications, address challenges within the diagnostics domain, including diagnostic settings, sample processing, regulations, validations, high costs of advanced technologies, challenges related to blood transfusion technology, and the global need for improved healthcare. It will also delve into topics such as vaccine efficacy, side effects, issues with test kits, and the importance of result accuracy.

This conference promises to attract an impressive gathering of influential healthcare and industry leaders who are shaping the future of the field. Their expertise and vision make them some of the brightest minds on the planet.

CO-LOCATED CONFERENCES

WHAT TO EXPECT

Key Sessions on Molecular Diagnostics:


•    Developing a Molecular and Rapid Testing Diagnostic Service
•    The Impact of NGS in Diagnostic Virology Involving HIV-1 Tropism, Genotypic Resistance in Influenza, HBV, Hepatitis C Virus (HCV) and Cytomegalovirus (CMV)
•    Current Molecular Diagnostics and Whole Genome Sequencing (WGS) Applied to Mycobacteria
•    KCL TEST: Matching Results from the ONS and Generating Molecular Biology Laboratory-Based Protocols  
•    Molecular Diagnosis of Drug-Resistant Tuberculosis

Key Sessions on Infectious Diseases:


•    Clinical Validation of a Point-of-Care Multiplexed In Vitro Immunoassay Using Monoclonal Antibodies
•    The Impact of Digital Technologies on Point-of-Care Diagnostics in Resource-Limited Settings.
•    The Challenges and Some Emerging Strategies for Tackling a Global Bacterial Menace
•    Biosensors for the Detection of Bacterial and Viral Clinical Pathogens
•    Electrochemical Diagnostics of Infectious Viral Diseases 
 

Stay Updated: The conference provides a platform to gain insights into the latest advancements, trends, and innovations in infectious disease diagnostics and molecular diagnostics.

Networking Opportunities: With 120+ professionals attending the conference provides an excellent opportunity to network, forge valuable connections, and collaborate with like-minded individuals who share a passion for diagnostics and healthcare.

Knowledge Exchange: The conference features discussions, presentations, and interactive sessions led by industry experts and thought leaders.

Emerging Technologies: The conference focuses on trending technologies in diagnostics and their applications. By attending, you can gain insights into emerging tools, platforms, and methodologies that can enhance diagnostic accuracy, speed, and precision.

Address Challenges: The conference addresses challenges faced in the diagnostics field. By participating, you can learn about potential solutions and best practices to overcome these hurdles in the diagnostics world.

Global Healthcare Perspectives: The conference examines the need for improved healthcare worldwide and explores how diagnostics can contribute to this goal. You can gain a broader understanding of the global healthcare landscape and discover ways to facilitate better healthcare outcomes on a global scale.

Vaccine Insights: The event also covers topics related to vaccine efficacy, side effects, and their impact on diagnostics.

Professionals in Hospitals/Universities/Labs:

•          Hospitals - Department of infectious diseases. Department of hematology, Department of Genomics, Diagnostics Department, Molecular Biology, Molecular Genetics

•          Hospital Designations - Senior scientist, scientist, Microbiologist, biologists, pathologist, General

•          Practitioners, Lab managers, Lab directors, medical directors, POCT coordinators

•          Universities Designations- Professors, Researchers, Associate professors, Deans, Senior Professors

•          Hospital Laboratories Designations- Pathologists, Lab managers, Lab Directors, Clinicians

CONFERENCE AGENDA

Registration

08:15 - 08:55

Welcome note from MarketsandMarkets

08:55 - 09:00

Opening remarks from the Chairman

Senior Representative, Co-Diagnostics, Inc

Senior Representative, Co-Diagnostics, Inc, Senior Representative, Co-Diagnostics, Inc

09:00 - 09:10

ADAPTING MOLECULAR DIAGNOSTICS FOR EVOLVING DISEASES

Keynote - Presentation by

Senior Representative, Co-Diagnostics, Inc

Senior Representative, Co-Diagnostics, Inc, Senior Representative, Co-Diagnostics, Inc

09:10 - 09:40

Developing a Molecular and Rapid Testing Diagnostic Service

Stuart Whitmore

Stuart Whitmore, Molecular Laboratory Manager, East Suffolk and North Essex NHS Foundation Trust

09:40 - 10:10

TBA

TBA, Senior Representative, AusDiagnostics

TBA, Senior Representative, AusDiagnostics, ,

10:10 - 10:40

Morning Refreshments and Poster Presentation | One-to-One Networking Meetings

10:40 - 11:30

TBA

TBA, Senior Representative, Eurobio Scientific

TBA, Senior Representative, Eurobio Scientific, ,

11:30 - 11:50

REDESIGNING DIAGNOSTICS WITH NEXT-GEN TECHNOLOGIES

Antimicrobial Resistance and Testing

Helen Dent

Helen Dent, Chief Operating Officer, BIVDA

11:50 - 12:20

TBA

TBA, Senior Representative, Randox Laboratories

TBA, Senior Representative, Randox Laboratories, ,

12:20 - 12:40

Reserved Slot for Silver Sponsor

12:40 - 13:00

Lunch and Poster Presentation | One-to-One Networking Meetings

13:00 - 14:00

KCL TEST: Matching Results from the ONS and Generating Molecular Biology Laboratory-Based Protocols

14:00 - 14:30

SHAPING THE CUSTOMIZED MODEL’S AND ADVANCEMENTS IN POINT OF CARE TESTING FOR INFECTIOUS DISEASE DIAGNOSTICS

Modern Tools for Rapid Diagnostics of Antimicrobial Resistance

Dushyanthie Athukorala

Dushyanthie Athukorala, Consultant in Microbiology, UHCW NHS Trust

14:30 - 15:00

Afternoon Refreshments and Poster Presentation | One-to-One Networking Meetings

15:00 - 15:50

SHAPING THE POINT OF CARE ERA WITH BEST TOOLS AND METHODOLOGIES

The Impact of Digital Technologies on Point-of-Care Diagnostics in Resource-Limited Settings.

15:00 - 15:30

ENCOURAGING DIAGNOSTIC TECHNIQUES IN THE ERA OF CONSOLIDATION

Blood Borne Virus Screen (BBV) testing in emergency departments – Pathology perspective o Why use BBV opt-out testing in EDs? o Problems and accomplishment o Future Plans

Dipti Patel

Dipti Patel, Infection and Immunity Lead | Scientist/Manager, Imperial College Healthcare NHS Trust

15:50 - 16:20

Reworking qPCR for extreme and point-of-care applications Demonstration of low denaturation, high polymerisation temperature qPCR Demonstration of extreme PCR completing 30 cycles in less than 2 minutes • Low ∆T qPCR • Extreme PCR • 1-step RT-qPCR with no dedicated RT step

Stephen Bustin

Stephen Bustin, Professor of Molecular Medicine, Medical Technology Research Centre, Anglia Ruskin University, UK

16:20 - 16:50

Testing Immunity Against Disease and Using this Information-to-Information Vaccine Strategy

Jennifer Heaney

Jennifer Heaney, Researcher, University of Birmingham

16:50 - 17:20

Closing Remarks from the Chairperson

Senior Representative, Co-Diagnostics, Inc

Senior Representative, Co-Diagnostics, Inc, Senior Representative, Co-Diagnostics, Inc

17:20 - 17:20

Drinks Reception & Networking End of Day 1

17:20 - 17:20

Registration

08:15 - 08:55

Welcome note from MarketsandMarkets

08:55 - 09:00

Opening remarks from the Chairman

Senior Representative, Co-Diagnostics, Inc

Senior Representative, Co-Diagnostics, Inc, Senior Representative, Co-Diagnostics, Inc

09:00 - 09:10

FUTURE MOLECULAR DIAGNOSTICS AND NEW DIAGNOSTIC TECHNOLOGIES

Molecular Diagnostic Testing: Actionable Results for Challenging Carbapenemase-Producing Organisms

David Nicolau

David Nicolau, Chief, Preclinical Development and Commercial Strategies Center for Anti-Infective Research & Development H

09:10 - 09:40

Technological advances in Infectious Diseases diagnostics: New lamps for Old?

Elfatih Mustafa Awadel-Kariem

Elfatih Mustafa Awadel-Kariem, Consultant Microbiologist & Director for Infection Prevention & Control (DIPC), Basildon and Thurrock NHS University Hospital, Mid and South Essex NHS Foundation Trust

09:40 - 10:10

Metagenomics-Based Diagnostics

10:10 - 10:40

Morning Refreshments and Poster Presentation | One-to-One Networking Meetings

10:40 - 11:30

Molecular Diagnosis of Drug-Resistant Tuberculosis

11:30 - 12:00

Advancing the Point of Care Frontier with Pinnacle Tools and Approaches

Biosensors for the Detection of Bacterial and Viral Clinical Pathogens

12:00 - 12:30

Modern Tools for Rapid Diagnostics of Antimicrobial Resistance

12:30 - 13:00

Lunch and Poster Presentation | One-to-One Networking Meetings

13:00 - 14:00

The Challenges and Some Emerging Strategies for Tackling a Global Bacterial Menace

14:00 - 14:30

SHAPING THE POINT OF CARE ERA WITH BEST TOOLS AND METHODOLOGIES

Emerging Pathogens: Challenges and Successes of Molecular Diagnostics

14:30 - 15:00

Panel Discussion: Virology Remains a Rapidly Changing Field and the Diagnostic Clinical Laboratory must keep Abreast of newer Viruses, Targets and Technologies

15:30 - 16:00

Closing Remarks from the Chairperson

Senior Representative, Co-Diagnostics, Inc

Senior Representative, Co-Diagnostics, Inc, Senior Representative, Co-Diagnostics, Inc

16:00 - 16:00

End of Conference

16:00 - 16:00

CONFERENCE SPEAKERS

ADVISORS

Rocio T. Martinez Nunez

Rocio T. Martinez Nunez

Senior Lecturer, Dept. Infectious Diseases, School of Immunology & Microbial Sciences, King College London

Elfatih Mustafa Awadel-Kariem

Elfatih Mustafa Awadel-Kariem

Consultant Microbiologist & Director for Infection Prevention & Control (DIPC), Basildon and Thurrock NHS University Hospital, Mid and South Essex NHS Foundation Trust

Peter Munthali

Peter Munthali

Consultant- Bacteriology · Microbiology, University Hospital Coventry

Tina Joshi

Tina Joshi

Chair of the Federation of Infection Societies (FIS) for the Microbiology Society | Deputy Editor-in-Chief: Journal of Medical Microbiology (Microbiology Society) | Council & Trustee- Microbiolo, Antibiotic Research UK (ANTRUK)

SPEAKERS

Preetha Shibu

Preetha Shibu

Senior Biomedical Scientist and Quality Lead, Frimley NHS Trust

David Nicolau

David Nicolau

Chief, Preclinical Development and Commercial Strategies Center for Anti-Infective Research & Development H

Dipti Patel

Dipti Patel

Infection and Immunity Lead | Scientist/Manager, Imperial College Healthcare NHS Trust

Stephen Bustin

Stephen Bustin

Professor of Molecular Medicine, Medical Technology Research Centre, Anglia Ruskin University, UK

Thomas Blanchard

Thomas Blanchard

Consultant in Infectious Disease, Liverpool University Hospitals NHS Foundation Trust

Jennifer Heaney

Jennifer Heaney

Researcher, University of Birmingham

Dushyanthie Athukorala

Dushyanthie Athukorala

Consultant in Microbiology, UHCW NHS Trust

Helen Dent

Helen Dent

Chief Operating Officer, BIVDA

Parisa Nakhostin Mortazavi

Parisa Nakhostin Mortazavi

Research Assistant, Birkbeck College

TBA, Senior Representative, Eurobio Scientific

TBA, Senior Representative, Eurobio Scientific

,

TBA, Senior Representative, Randox Laboratories

TBA, Senior Representative, Randox Laboratories

,

TBA, Senior Representative, AusDiagnostics

TBA, Senior Representative, AusDiagnostics

,

TBA, Senior Representative, OLM Diagnostics

TBA, Senior Representative, OLM Diagnostics

,

Stuart Whitmore

Stuart Whitmore

Molecular Laboratory Manager, East Suffolk and North Essex NHS Foundation Trust

Dwight Egan

Dwight Egan

Chief Executive Officer, Co-Diagnostics, Inc

Peter Munthali

Peter Munthali

Consultant- Bacteriology · Microbiology, University Hospital Coventry

Elfatih Mustafa Awadel-Kariem

Elfatih Mustafa Awadel-Kariem

Consultant Microbiologist & Director for Infection Prevention & Control (DIPC), Basildon and Thurrock NHS University Hospital, Mid and South Essex NHS Foundation Trust

ENQUIRE NOW

SPONSORS

Co-Diagnostics Inc.
OLM Dx
AusDiagnostics
Eurobio Scientific
Randox
BD Biosciences

LOCATION

Venue

London, UK

PAST EVENT GALLERY